Evidence map›Paper›PMID 36763323›Full record

ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2023

Synthesis and physicochemical evaluations of a novel MIL-101(Fe)-PMA-Biochar triple composite photocatalyst activated through visible-light and utilized toward degradation of organic pollutants: optimal operations and kinetics investigations.

Alireza Mohammadi, Mohammad Kazemeini, Samahe Sadjadi

Abstract read
PubMed Publisher
In one paragraph

Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alireza MohammadiDepartment of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran.
Mohammad KazemeiniDepartment of Chemical and Petroleum Engineering, Sharif University of Technology, Tehran, Iran. kazemini@sharif.edu.ORCID http://orcid.org/0000-0001-5681-962X
Samahe SadjadiGas Conversion Department, Faculty of Petrochemicals, Iran Polymer and Petrochemical Institute, Tehran, Iran. s.sadjadi@ippi.ac.ir.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A triple photocatalytic composite of biochar, metal-organic framework, and phosphomolybdic acid was prepared through hydrothermal treatment of iron (III) chloride hexahydrate, terephthalic acid, lavandulifolia-derived biochar, and phosphomolybdic acid. It was characterized and utilized for photodegradation of Rhodamine-B (RhB) dye under visible-light irradiation. Investigations of reaction variables confirmed that, the highest yield of 96.2% was achieved at ambient temperature using 0.07 g of catalyst at pH of 7, and a dye concentration of 10 ppm. Under these optimum conditions, Methyl Orange (MO) dye was also degraded to yield 93% removal. In addition, the kinetic and thermodynamic parameters for RhB were determined. It was revealed that the photodegradation of RhB followed a pseudo-first-order kinetics with no mass transfer limitations. A corresponding chemical mechanism for this process was also suggested. Adsorption isotherms were investigated for rate of adsorption as well as adsorption capacity of the catalyst under dark conditions. Notably, the catalyst could have been reused for five cycles with a loss of around 20% activity.

Indexed as

Environmental PollutantsMetal-Organic FrameworksCharcoalKineticsMolybdenumPhosphoric AcidsbiocharCharcoalEnvironmental PollutantsMetal-Organic FrameworksMIL-101Molybdenumphosphomolybdic acidPhosphoric AcidsBiocharHeteropolyacidMetal-organic frameworkPhotocatalysis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.